gastric cancer
Mirxes Gets $40M Financing From CBC Group's R-Bridge to Support Global Expansion
The company is developing blood-based microRNA tests for early cancer detection and screening, with its flagship assay, GastroClear, already approved as an IVD in Singapore.
Roche CDx Test Receives CE Marking for Use in Gastric Cancer Patients
The IHC companion diagnostic test determines CLDN18 protein expression and may help identify patients who are eligible for treatment with Vyloy.
Agilent, Transcenta Ink CDx Development Deal for Stomach Cancer Therapy Trial
The immunohistochemistry assay will be used to aid patient selection for a Phase III clinical trial of osemitamab plus Opdivo (nivolumab) and chemotherapy.
Agilent Gets FDA Approval of Expanded Use of CDx Assay for Keytruda
The firm said it secured agency approval for its PD-L1 IHC 22C3 PharmDx test to guide treatment of patients with gastric or GEJ adenocarcinoma.
FDA Grants Marketing Authorization for Invitae Hereditary Cancer DNA Sequencing Test
The Invitae Common Hereditary Cancers Panel is the first test of its kind to obtain FDA marketing authorization, creating an easier pathway for similar tests.